Tharimmune Announces Intent to Acquire Intract Pharma

Tharimmune ( (THAR) ) has shared an announcement.

Tharimmune, Inc. has announced its intent to acquire Intract Pharma Limited, aiming to purchase all outstanding shares of Intract in a stock-for-stock transaction. This significant move, intended to expand Tharimmune’s market presence, should be considered alongside the company’s other public disclosures. However, investors are cautioned to not place undue reliance on forward-looking statements provided in the presentation material.

Find detailed analytics on THAR stock on TipRanks’ Stock Analysis page.